HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amelioration of mitochondrial dysfunction-induced insulin resistance in differentiated 3T3-L1 adipocytes via inhibition of NF-κB pathways.

Abstract
A growing body of evidence suggests that activation of nuclear factor kappa B (NF-κB) signaling pathways is among the inflammatory mechanism involved in the development of insulin resistance and chronic low-grade inflammation in adipose tissues derived from obese animal and human subjects. Nevertheless, little is known about the roles of NF-κB pathways in regulating mitochondrial function of the adipose tissues. In the present study, we sought to investigate the direct effects of celastrol (potent NF-κB inhibitor) upon mitochondrial dysfunction-induced insulin resistance in 3T3-L1 adipocytes. Celastrol ameliorates mitochondrial dysfunction by altering mitochondrial fusion and fission in adipocytes. The levels of oxidative DNA damage, protein carbonylation and lipid peroxidation were down-regulated. Further, the morphology and quantification of intracellular lipid droplets revealed the decrease of intracellular lipid accumulation with reduced lipolysis. Moreover, massive production of the pro-inflammatory mediators tumor necrosis factor-α (TNF-α) and interleukin-1β (IL-1β) were markedly depleted. Insulin-stimulated glucose uptake activity was restored with the enhancement of insulin signaling pathways. This study signified that the treatments modulated towards knockdown of NF-κB transcription factor may counteract these metabolic insults exacerbated in our model of synergy between mitochondrial dysfunction and inflammation. These results demonstrate for the first time that NF-κB inhibition modulates mitochondrial dysfunction induced insulin resistance in 3T3-L1 adipocytes.
AuthorsMohamad Hafizi Abu Bakar, Mohamad Roji Sarmidi, Cheng Kian Kai, Hasniza Zaman Huri, Harisun Yaakob
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 15 Issue 12 Pg. 22227-57 (Dec 02 2014) ISSN: 1422-0067 [Electronic] Switzerland
PMID25474091 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Glucose Transporter Type 1
  • Glucose Transporter Type 4
  • Insulin
  • Interleukin-1beta
  • NF-kappa B
  • Oligomycins
  • Pentacyclic Triterpenes
  • Triterpenes
  • Tumor Necrosis Factor-alpha
  • Glucose
  • celastrol
Topics
  • 3T3-L1 Cells
  • Adipocytes (cytology, drug effects, metabolism)
  • Animals
  • Cell Differentiation (drug effects)
  • Cell Survival (drug effects)
  • Electron Transport (drug effects)
  • Glucose (metabolism)
  • Glucose Transporter Type 1 (metabolism)
  • Glucose Transporter Type 4 (metabolism)
  • Humans
  • Insulin (pharmacology)
  • Insulin Resistance
  • Interleukin-1beta (biosynthesis)
  • Intracellular Space (drug effects, metabolism)
  • Lipolysis (drug effects)
  • Mice
  • Mitochondria (drug effects, metabolism, pathology)
  • NF-kappa B (metabolism)
  • Oligomycins (chemistry, pharmacology)
  • Oxidative Stress (drug effects)
  • Pentacyclic Triterpenes
  • Signal Transduction (drug effects)
  • Triterpenes (chemistry, pharmacology)
  • Tumor Necrosis Factor-alpha (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: